ÕÐÉúÀàÐÍ£º½ÓÊܵ÷¼Á
ѧУ¼°Ñ§Ôº£º»ªÄÏÅ©Òµ´óѧ£¬ÉúÃü¿ÆѧѧԺ
ѧУµØµã£º¹ã¶«£¬¹ãÖÝ
ÌṩµÄ²¹Öú´ýÓö£º°´Ñ§Ð£¹æ¶¨·¢·Å
ѧÖƼ°×¨Òµ:ÈýÄêÖÆר˶£¬ÉúÎ﹤³Ìרҵ
ÕÐÉúÄ꼶: 2018¼¶
ÕÐÉúÒªÇó£º1£¬¶Ô΢ÉúÎï·¢½Í¼°ÃâÒßѧµÈ·½Ãæ¸ÐÐËȤ£»
2£¬ÊýѧÄÜÁ¦½ÏºÃ£»
3£¬¶Ô¼ÆËã»ú±à³Ì½ÏΪÊìϤÁ˽⡣
Ä¿Ç°Õâ±ß¹À¼ÆÓÐÒ»¸öר˶µ÷¼ÁÃû¶î£¬Ï£Íû·ûºÏѧУºÍµ÷¼ÁרҵҪÇóµÄѧÉú£¬¶øÇÒ¶Ô±¾¿ÎÌâ×éµÄÑо¿¸ÐÐËȤ£¬ÓÐÖ¾ÓÚÔÚÕâ¸öÁìÓò×ö³öµã³É¹ûµÄ£¬¿ÉÒÔÓ»Ô¾µ÷¼Á£¡
µ¼Ê¦Çé¿ö£º
ÕÅÁỪ:¡¡½ÌÊÚ¡¡²©Ê¿Éúµ¼Ê¦¡¡¡¡ ÐÔ±ð: Å®
ËùÊôµ¥Î»£ºÉúÎﻯѧ¼°·Ö×ÓÉúÎïѧϵ
°ì¹«ÊÒ£º±±-213 °ì¹«Êҵ绰£º020-85281389
Email£ºlhzhang@scau.edu.cn
¸öÈ˼ò½é
ÕÅÁỪ£¬Å®£¬½ÌÊÚ£¬²©Ê¿£¬»ªÄÏÅ©Òµ´óѧÉúÃü¿ÆѧԺ΢ÉúÎï½ÌÑÐÊÒ¹¤×÷¡£
1973Äê3Ô³öÉú£¬1997Äê4ÔÂÓÚ»ªÄÏÀí¹¤´óѧ±ÏÒµ·ÖÅäÔڹ㶫ʡũ¿ÆÔºÉúÎï¼¼ÊõÑо¿ËùÒ»Ö±´ÓÊÂÃâÒß¼°Î¢ÉúÎïѧµÄÑо¿ÓëÏà¹Ø²úÆ·µÄ¿ª·¢£¬ÓÚ2005Äê×÷ΪÒý½øÈ˲ŵ÷È뻪ÄÏÅ©Òµ´óѧÉúÃü¿ÆѧԺ´ÓÊÂÃâÒß¼°Î¢ÉúÎï½ÌѧÓë¿ÆÑй¤×÷¡£2004ÄêÔÚ»ªÄÏÀí¹¤´óѧ¹¥¶Á²©Ê¿Ñ§Î»£¬ÓÚ2007Äê±ÏÒµÓÚ»ªÄÏÀí¹¤´óѧÉúÎ﹤³ÌÓë¿ÆѧѧԺ΢ÉúÎ﹤³ÌÑо¿·½Ïò¡£
ÏÖÖ÷³Ö¹ú¼Ò×ÔÈ»¿Æѧ»ù½ð¡°CpG ODNͨ¹ýNF-¦ÊBÐźÅϵͳÑÓ»ºTϸ°ûË¥ÀϵķÖ×Ó»úÖÆ¡±£¨31072114£©£¬¹ãÖÝÊÐÖصãÏîÄ¿¡°¿¹×ÐÖí¶ÏÄÌÓ¦¼¤¸¹ÐºCpGÖƼÁ¹Ø¼ü¼¼ÊõÑо¿¼°Ê¾·¶¡±ºÍ¹ã¶«Ê¡¹¥¹ØÏîÄ¿¡°Ó×Öí¸ßÈȲ¡ÒßÃçÃâÒßÔöЧ¼ÁCpGµÄÑо¿¼°Ó¦Óá±£¨2009B020307010£©£¬
Ö÷³ÖÍê³ÉÁ˹㶫ʡũҵ¹¥¹ØÏîÄ¿¡°ÐÂÐÍÐóÇÝÃâÒß×ô¼ÁCpG ÖÊÁ£¹¹½¨ÓëÃâÒß»îÐÔµÄÑо¿¡±£¬Ö÷³ÖÍê³ÉÁËÊ¡ÏîÄ¿¡°²ËµØÏõËáÑνµ½â¹¦ÄܾúȺµÄÑо¿¼°Ó¦Óá±£¬ºÍ¹ãÖÝÊÐÖصãÏîÄ¿¡°¸ßЧ¹¦ÄÜÐÍÏõËáÑνµ½â¾úȺµÄ¹¹½¨¼°ÆäÖƼÁµÄÉú²úºÍÓ¦Óá±£¬ÐÖúÖ÷³ÖÍê³ÉÁ˹ãÖÝÊÐÖص㹥¹ØÏîÄ¿¡°ÐÂÐÍÐóÇÝÃâÒßÔöÇ¿¼ÁCpGµÄ¿ª·¢Ó¦Óᱡ¢Ö÷³ÖÁ˹㶫ʡũ¿ÆÔº¹¥¹ØÏîÄ¿¡°ÖíÐÂÐÍϸ°ûÒò×ÓÃâÒß×ô¼ÁIL-6µÄ¿ª·¢ÓëÓ¦Óá±£¬´ËÍ⣬»¹ÐÖúÖ÷³ÖÍê³ÉÁË4ÏîÊ¡¡¢ÊÐÓйØÌá¸ßÑøÖ³¶¯ÎïÃâÒßÁ¦µÄÏîÄ¿£¬²Î¼Ó1Ïî¹ú¼ÒÅ©Òµ¿Æ¼¼³É¹ûת»¯ÏîÄ¿¡£
»ñÊ¡¼¶¿Æѧ¼¼Êõ½±¶þµÈ½±1ÏµÚ¶þÍê³ÉÈË£©¡¢¹ã¶«Ê¡Å©¿ÆÔº¿Æѧ¼¼Êõ½±¶þµÈ½±1ÏµÚ¶þÍê³ÉÈË£©¡¢Ã¯ÃûÊпÆѧ¼¼Êõ½±ÈýµÈ½±1ÏµÚÈýÍê³ÉÈË£©¡¢É걨·¢Ã÷רÀû3ÏÊÚȨ2Ï£¬×«Ð´Ñ§ÊõÂÛÎÄ50Óàƪ£¬ÆäÖУ¬SCIÂÛÎÄ13ƪ£¨ÒÑÊÕ¼13ƪ£©£¬²¢±»¡¶Vaccine¡·£¨Impact factor, 3.159£©¡¢¡¶International Immunopharmacology¡·£¨Impact factor, 2.157£©¡¢¡¶Scandinavian Journal of Immunology¡·£¨Impact factor, 2.090£©¡¢¡¶Indian Journal of Medical Research¡·£¨Impact factor, 1.224£©µÈÔÓÖ¾ÉçÑûÇëΪÉó¸åÈË£¨Reviewer£©¡£
Ñо¿·½Ïò
1¡¢¶¯ÎïÒßÃçµÄÑÐÖƼ°¶¯ÎïÃâÒßÌáÉý¼Á¿¹Ë¥ÀϵĻúÀíÑо¿£»
2¡¢ÍÁÈÀÓк¦²¡Ô´Î¢ÉúÎïµÄ·ÖÀëÓëÞ׿¹»úÀíÑо¿£»
Ïà¹Ø»ñ½±³É¹û
1¡¢ÌïÐËɽ£¬ÕÅÁỪ£¬Ê¯ºÍÈÙ£¬Ú÷ÕÜʦ£¬ÀÐÛ£¬¿ÂºÆ£¬ÅËľˮ£¬ÌÆС¿¡£¬Âí½Ò«£¬³ÂÞ±£¬»ÆÏþ¹â£¬Ð»º£Ñ࣬ÖÜ·çÕ䣬Àî¹úÁ¢£¬ËïÏþ¸Õ¡£¡°ÓÐÒæ΢ÉúÎïÖƼÁ´Ù½ø¶¯ÎïÉú³¤µÄÑо¿¼°Ó¦Óá± ͨ¹ýÊ¡¿Æ¼¼Ìü³É¹û¼ø¶¨£¬×ÜÌå´ï¹úÄÚÁìÏÈˮƽ£¬²¿·Ý¼¼Êõ´ïµ½¹ú¼ÊÁìÏÈˮƽ£¬2004Äê»ñ¹ã¶«Ê¡¿Æ¼¼½ø²½¶þµÈ½±¡£
2¡¢ÌïÐËɽ, ʯºÍÈÙ£¬ÕÅÁỪ£¬Õű룬Ú÷ÕÜʦ£¬ÌÆС¿¡£¬¿Â ºÆ£¬ÀÐÛ£¬Âí½Ò«£¬ÖÜ·çÕ䣬³ÂÞ±¡£ ¡°¶ÔϺÉú̬ÑøÖ³¼¼ÊõÑо¿¼°Ó¦Óá±£¬ 2004Äê¶È»ñµÃïÃûÊпƼ¼½ø²½ÈýµÈ½±¡£
½üÆÚ·¢±íÓë±¾ÏîÄ¿Ïà¹ØµÄ¿Æ¼¼ÂÛÎÄ
£¨1£©Cao, D., Li, H.Z., Jiang, Z.G, Xu, C.C., Cheng, Q., Yang, Z.H., Cao, G.J., Zhang, L.H. £ª£¨ÕÅÁỪ£©. £¨2010£© Synthetic innate defence regulator peptide enhances in vivo immunostimulatory effects of CpG-ODN in newborn piglets. Vaccine. 28, 6006¨C6013. £¨£ªÍ¨Ñ¶×÷Õߣ¬2009 SCI Impact factor, 3.616£©
£¨2£©Cheng, Q., Xu, C.C., Zhang, L.H. £ª, Li, J.Q., Cao, T., Zhang, M.R. £¨2010£© Administered CpG Oligodeoxynucleotide Induces mRNA expression of CXC and CC Chemokines at the Intestinal Mucosa and PBMCs in Piglets. Int. Immunopharmacol. 10, 611-618 £¨£ªÍ¨Ñ¶×÷Õߣ¬ 2009 SCI Impact factor, 2.214£©
£¨3£©Zhang Linghua, Tian Xingshan, Zhou Fengzhen.In vivo oral administration effects of various¡¡oligodeoxynucleotides containing synthetic immunostimulatory motifs in the immune response to pseudorabies attenuated virus vaccine in newborn piglets. Vaccine, 2008, 26, 224-233. £¨Impact factor, 3.159£©
£¨4£©Zhang Linghua, Tian Xingshan, Zhou Fengzhen. In vivo immunostimulatory effects of CpG ODN in newborn piglets. Molecular Immunology, 2007a, 44: 1238¨C1244. £¨Impact factor, 4.768£©
£¨5£©Zhang Linghua, Tian Xingshan, Zhou Fengzhen. In vivo effects of oligodeoxynucleotides containing synthetic immunostimulatory motifs in the immune response to swine streptococcic septicemia vaccine in weaned piglets. Molecular Immunology, 2007b, 44: 1141¨C1149. £¨Impact factor, 4.768£©
£¨6£©Zhang Linghua, Tian Xingshan, Zhou Fengzhen.Vaccination with porcine reproductive and respiratory syndrome killed virus vaccine and immunostimulatory oligodeoxynucleotides induces specific immunity in piglets. Vaccine, 2007, 25: 1735¨C1742. £¨Impact factor, 3.159£©
£¨7£©Zhang Linghua, Tian Xingshan, Zhou Fengzhen.Vaccination with Newcastle disease vaccine and CpG oligodeoxynucleotides induces specific immunity and protection against Newcastle disease virus in SPF chicken. Veterinary Immunology and Immunopathology, 2007, 115: 216¨C222. £¨Impact factor, 1.994£©
£¨8£©Zhang Linghua, Tian Xingshan, Zhou Fengzhen. Intranasal administration of CpG oligonucleotides induces mucosal and systemic Type 1 immune responses and adjuvant activity to porcine reproductive and respiratory syndrome killed virus vaccine in piglets in vivo. International Immunopharmacology, 2007, 7£¨13£©: 1732¨C1740. £¨Impact factor, 2.157£©
£¨9£©Zhang Linghua, Tian Xingshan, Zhou Fengzhen. CpG oligodeoxynucleotides augment the immune responses of piglets to swine Pasteurella multocida living vaccine in vivo. Research in Veterinary Science, 2007, 83£¨2£©:171-181. £¨Impact factor, 1.258£©
£¨10£©ÕÅÁỪ, ÌïÐËɽ, ÖÜ·çÕä. CpG-ODN¶Ô×ÐÖíÁÜ°Íϸ°ûÔöÖ³·´Ó¦ºÍϸ°ûÒò×ÓÓÕÉúµÄÓ°Ïì: ÔÚÌåºÍÀëÌåÊÔÑé. ÖйúÊÞҽѧ±¨, 2007, 27£¨1£©:46-50.
£¨11£©Zhang Linghua, Guo Yong, Tian Xingshan, Zhou Fengzhen. Co-administration of porcine-specific CpG oligodeoxynucleotide enhances the immune responses to pseudorabies attenuated virus vaccine in newborn piglets in vivo. Developmental and Comparative Immunology, 2006a, 30£¨6£©: 589-596. £¨Impact factor, 3.261£©
£¨12£©Zhang Linghua, Tian Xingshan, Guo Yong, Zhou Fengzhen. Effects of CpG ODN on CD4+ and CD8+ T subpopulations in the immune response to porcine reproductive and respiratory syndrome killed virus vaccine. Vaccine, 2006b, 24£¨11£©: 1874-1879 . £¨Impact factor, 2.822£©
£¨13£©Zhang Linghua, Tian Xingshan, Zhou Fengzhen. The efficacy of CpG oligodinucleotides, in combination with conventional adjuvants, as immunological adjuvants to swine streptococcic septicemia vaccine in piglets in vivo. International Immunopharmacology, 2006c, 6£¨8£©: 1267-1276. £¨Impact factor, 2.008£©
£¨14£©Zhang Linghua, Tian Xingshan, Zhou Fengzhen. In vivo effects of oligodeoxynucleotides containing synthetic immunostimulatory motifs in weaned piglets. International Immunopharmacology, 2006d, 6£¨10£©:1623-1631. £¨Impact factor, 2.008£©
£¨15£©Zhang Linghua, Guo Yong, Tian Xingshan, Zhou Fengzhen. CpG oligodinucleotides induce strong humoral and cellular responses to swine streptococcic septicemia vaccine in piglets in vivo. International Immunopharmacology, 2006e, 6£¨3£©:342-350. £¨Impact factor, 2.008£©
£¨16£©Zhang Linghua, Tian Xingshan, Guo Yong, Zhou Fengzhen. The effect of transgenic expression of porcine interleukin-6 gene and CpG sequences on immune responses of the newborn piglets inoculated with pseudorabies attenuated vaccine. Research in Veterinary Science, 2006f, 80: 281-286. £¨Impact factor, 1.106£©
£¨17£©·ëÀò, ÕÅÁỪ, ÌïÐËɽ. Çà¿Ý¾úÖ²¡ÐÔÓë»ùÒò×éÖ®¼äµÄ¹Øϵ. ÉúÎï¼¼ÊõͨѶ. 2007,18£¨2£©:357-359.
£¨18£©·ëÀò, ÕÅÁỪ, ÌïÐËɽ. Ö²ÎﲡÔ΢ÉúÎï Type III·ÖÃÚϵͳ. ÉúÃüµÄ»¯Ñ§.¡¡´ý·¢±í.
£¨19£©ÕÅÁỪ, ·ëÀò, ÌïÐËɽ. ¼Ùµ¥°û¾úQuorum sensingµ÷¿ØÌåϵ. ÉúÎï¼¼Êõ. 2006, 16£¨6£©:86-89.
£¨20£©ÕÅÁỪ, ·ëÀò, ÌïÐËɽ. Ö²ÎïÏà¹Øϸ¾ú»ùÒò×éÔÚϸ¾ú£Ö²ÎïÖ®¼äÏ໥×÷ÓÃÑо¿ÖеÄ×÷ÓÃ. ÒÅ´«. 2007,29£¨6£©:675-680.
£¨21£©ÕÅÁỪ, ¹ùÓÂ, ÌïÐËɽ. CpG ODN¶Ô³õÉú×ÐÖíÍâÖÜѪCD4+¡¢CD8+ TÁÜ°Íϸ°ûµÄÓ°Ïì. »ªÄÏÀí¹¤´óѧѧ±¨, 2006, 34£¨5£©: 63-67.
£¨22£©ÌïÐËɽ, ÕÅÁỪ, ÖÜ·çÕä. È˹¤ºÏ³ÉÃâÒߴ̼¤CpG DNAÁªºÏ¼¦Ð³ÇÒßÒßÃç¶ÔSPF¼¦ÃâÒßÓ¦´ðµÄÓ°Ïì, ÖйúÊÞҽѧ±¨, 2006, 26£¨1£©:14-16.
£¨23£©ÕÅÁỪ, ¹ùÓÂ, ÌïÐËɽ, ÅËľˮ, »ÆС¹â, ÖÜ·çÕä, Ú÷ÕÜʦ, Àî¹úÁ¢, ËïÏþ¸Õ, ³ÂÞ±.ÐóÇÝÒßÃç×ô¼ÁÑо¿½øÕ¹.ÉúÎï¼¼ÊõͨѶ, 2005, 16£¨2£©:231-233.
£¨24£©ÕÅÁỪ, ¹ùÓÂ, ÌïÐËɽ, ÅËľˮ, »ÆС¹â, ÖÜ·çÕä, Ú÷ÕÜʦ, Àî¹úÁ¢, ËïÏþ¸Õ, ³ÂÞ±. TollÑùÊÜÌåʶ±ð»úÖƼ°ÆäÉúÎïѧÒâÒå. ÉúÎï¼¼ÊõͨѶ, 2005, 16£¨16£©:333-336.
£¨25£©ÕÅÁỪ, ¹ùÓÂ, ÌïÐËɽ, Ú÷ÕÜʦ, ÖÜ·çÕä. °×ϸ°û½éËØ-6µÄ·Ö×ÓÉúÎïѧÑо¿½øÕ¹ÆäÔÚÐóÇÝÒµÖеÄÓ¦ÓÃÇ°¾°, ÖйúÐóÄÁÊÞÒ½, 2005, 32£¨2£©:31-33.
£¨24£©ÕÅÁỪ, ¹ùÓµÈ. TLR9ÊÜÌå -----CpG DNAÌØÒìÐÔʶ±ðµÄ¹Ø¼üµ°°×.ÉúÎï¼¼ÊõͨѶ, 2005£¬16£¨4£©: 438-441.
£¨26£©´ÞìÇ, ÌïÐËɽ, ÕÅÁỪ, Àî×ÚÒå. ÃâÒߴ̼¤¼ÁCpG DNAÔÚ¼¦ÖеÄÑо¿½øÕ¹. ÉúÎï¼¼Êõ, 2005, 15£¨4£©: 79-82.
£¨27£© ´ÞìÇ, ÌïÐËɽ, ÕÅÁỪ, Àî×ÚÒå. CpG ODN¶Ô´«È¾ÐÔÇ»ÉÏÄÒ²¡²¡¶¾»îÒßÃçÃâÒßЧ¹ûµÄÓ°Ïì. ÖйúÊÞÒ½¿Æ¼¼, 2005, 5: 353-357.
£¨28£©ÕÅÁỪ, ¹ùÓÂ, ÌïÐËɽ, ÖÜ·çÕä. CpG ODN¶ÔÖí·±Ö³ºôÎü×ÛºÏÖ¢ÒßÃçÃâÒßÓ°ÏìµÄÑо¿ .ÖйúÐóÄÁÊÞÒ½, 2005, 32£¨8£©:47-49.
£¨29£©ÕÅÁỪ, ÌïÐËɽ, Õű¦Áá.CpGÐòÁжÔÖíα¿ñÈ®ÒßÃçÃâÒßЧ¹ûµÄÓ°Ïì. ÖйúÐóÄÁÊÞÒ½, 2004, 31£¨3£©:37-39.
£¨30£©ÌïÐËɽ, ÕÅÁỪ, Ú÷ÕÜʦ, ³ÂÞ±, ÀÐÛ.²»Í¬Å¨¶ÈÌݶÈCpG DNA ¶Ô×ÐÖíÃâÒßÔöǿЧ¹ûµÄÑо¿. »ªÄÏÅ©Òµ´óѧѧ±¨, 2004, 25£¨1£©:96-98.
£¨31£©ÕÅÁỪ, ÌïÐËɽ, Õű¦Áá.CpGÐòÁÐÃâÒß¼¤»îÌØÐÔ¼°ÆäÓ¦ÓÃÇ°¾°.ÖйúÐóÄÁÊÞÒ½, 2003, 30£¨3£©:38-40.
Ïà¹ØרÀû
£¨1£© ÕÅÁỪ£¬ÌïÐËɽ£¬Ú÷ÕÜʦ£¬³ÂÞ±£¬ÀÐÛ¡£¡°ÓÐÒæ΢ÉúÎïÖƼÁÎȶ¨»¯Ô¤´¦Àí¹¤ÒÕ¡±£¨×¨ÀûºÅZL200310117512.8£©£¬ÒÑÊÚȨ¡£
£¨2£© Ú÷ÕÜʦ£¬ÌïÐËɽ£¬ÕÅÁỪ£¬³ÂÞ±£¬ÀÐÛ¡£¡°ÓÐÒæ΢ÉúÎïÖƼÁÎȶ¨»¯ºó´¦Àí¹¤ÒÕ¡±£¨×¨ÀûºÅZL200310117511.3£©£¬ÒÑÊÚȨ¡£
£¨3£©Ú÷ÕÜʦ£¬ÕÅÁỪ£¬ÐìÖ¾ºê¡£¡°Ò»ÖÖ΢ÉúÎïת»¯²¤ÂÜÔüΪÉúÎïËÇÁϵÄÖƱ¸·½·¨¡±£¨×¨ÀûºÅ£ºZL200610033024.2£©ÒÑÊÚȨ¡£
£¨4£© ÕÅÁỪ£¬ÏÄ·ã¹¢£¬Ã÷·Éƽ¡£¡°Ò»Öָ߻îÐԵĿݲÝÑ¿æ߸˾úµÄ·¢½Í·½·¨ºÍ·¢½Í²úÆ·¡±£¨ÉêÇëºÅ200910193082.5£©¡£ |